Moreover, the study demonstrated that elevated level of IL-6 was associated with higher Gensini scores, and CAD patients exhibited higher concentrations of this biomarker and sIL-6Rα compared with healthy postmenopausal women.[46] In a separate investigation, researchers found that individuals with chronic or acute CAD showed notably lower levels of sgp130 in comparison to the control subjects without CAD. Here, IL6 is linked to coronary artery disorder.